Skip to main content

Advertisement

SpringerLink
Log in

A systematic approach to the endocrine care of survivors of pediatric hematopoietic stem cell transplantation

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Hematopoietic stem cell transplantation (HSCT) is used in children to treat a variety of malignant and nonmalignant hematologic conditions and certain inborn errors of metabolism. Survivors of HSCT are markedly affected by disease and treatment toxicity. Endocrine complications are among the most commonly reported chronic health conditions in this population. In this review, we summarize the most common endocrine late effects after pediatric HSCT. We also highlight the importance of systematic and longitudinal evaluations to achieve early diagnoses and treatment for these conditions and improve the long-term health outcomes for patients who received HSCT as children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gyurkocza, B., & Sandmaier, B. M. (2014). Conditioning regimens for hematopoietic cell transplantation: One size does not fit all. Blood, 124(3), 344–353. https://doi.org/10.1182/blood-2014-02-514778.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ruutu, T., Gratwohl, A., de Witte, T., Afanasyev, B., Apperley, J., Bacigalupo, A., Dazzi, F., Dreger, P., Duarte, R., Finke, J., Garderet, L., Greinix, H., Holler, E., Kröger, N., Lawitschka, A., Mohty, M., Nagler, A., Passweg, J., Ringdén, O., Socié, G., Sierra, J., Sureda, A., Wiktor-Jedrzejczak, W., Madrigal, A., & Niederwieser, D. (2014). Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. Bone Marrow Transplantation, 49(2), 168–173. https://doi.org/10.1038/bmt.2013.107.

    Article  CAS  PubMed  Google Scholar 

  3. Eissa, H. M., Lu, L., Baassiri, M., Bhakta, N., Ehrhardt, M. J., Triplett, B. M., Green, D. M., Mulrooney, D. A., Robison, L. L., Hudson, M. M., & Ness, K. K. (2017). Chronic disease burden and frailty in survivors of childhood HSCT: A report from the St. Jude lifetime cohort study. Blood Adv, 1(24), 2243–2246. https://doi.org/10.1182/bloodadvances.2017010280.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Armenian, S. H., Sun, C. L., Kawashima, T., Arora, M., Leisenring, W., Sklar, C. A., Baker, K. S., Francisco, L., Teh, J. B., Mills, G., Wong, F. L., Rosenthal, J., Diller, L. R., Hudson, M. M., Oeffinger, K. C., Forman, S. J., Robison, L. L., & Bhatia, S. (2011). Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: A report from the bone marrow transplant survivor study (BMTSS) and childhood Cancer survivor study (CCSS). Blood, 118(5), 1413–1420. https://doi.org/10.1182/blood-2011-01-331835.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hows, J. M., Passweg, J. R., Tichelli, A., Locasciulli, A., Szydlo, R., Bacigalupo, A., et al. (2006). Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors. Bone Marrow Transplant, 38(12), 799–805. https://doi.org/10.1038/sj.bmt.1705531.

    Article  CAS  PubMed  Google Scholar 

  6. Leung, W., Ahn, H., Rose, S. R., Phipps, S., Smith, T., Gan, K., et al. (2007). A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore), 86(4), 215–224. https://doi.org/10.1097/MD.0b013e31812f864d.

    Article  Google Scholar 

  7. Baker, K. S., Ness, K. K., Weisdorf, D., Francisco, L., Sun, C. L., Forman, S., et al. (2010, Leukemia). Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: A report from the bone marrow transplant survivor study., 24(12), 2039–2047. https://doi.org/10.1038/leu.2010.210.

  8. Thomas, B. C., Stanhope, R., Plowman, P. N., & Leiper, A. D. (1993). Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood. Acta Endocrinol.(Copenh), 128(6), 508–512.

    Article  CAS  Google Scholar 

  9. Chemaitilly, W., Boulad, F., Heller, G., Kernan, N. A., Small, T. N., O'Reilly, R. J., et al. (2007). Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone Marrow Transplant, 40(1), 29–35. https://doi.org/10.1038/sj.bmt.1705694.

    Article  CAS  PubMed  Google Scholar 

  10. Barfield, R. C., Kasow, K. A., & Hale, G. A. (2008). Advances in pediatric hematopoietic stem cell transplantation. Cancer Biology & Therapy, 7(10), 1533–1539.

    Article  Google Scholar 

  11. Baird, K., Cooke, K., & Schultz, K. R. (2010). Chronic graft-versus-host disease (GVHD) in children. Pediatric Clinics of North America, 57(1), 297–322. https://doi.org/10.1016/j.pcl.2009.11.003.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Shalitin, S., Phillip, M., Stein, J., Goshen, Y., Carmi, D., & Yaniv, I. (2006). Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplant, 37(12), 1109–1117. https://doi.org/10.1038/sj.bmt.1705374.

    Article  CAS  PubMed  Google Scholar 

  13. Vantyghem, M. C., Cornillon, J., Decanter, C., Defrance, F., Karrouz, W., Leroy, C., le Mapihan, K., Couturier, M. A., de Berranger, E., Hermet, E., Maillard, N., Marcais, A., Francois, S., Tabrizi, R., Yakoub-Agha, I., & Société Française de Thérapie Cellulaire. (2014). Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation. Orphanet Journal of Rare Diseases, 9, 162. https://doi.org/10.1186/s13023-014-0162-0.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Chemaitilly, W., & Sklar, C. A. (2007). Endocrine complications of hematopoietic stem cell transplantation. Endocrinol.Metab Clin.North Am., 36(4), 983–998. https://doi.org/10.1016/j.ecl.2007.07.002.

    Article  CAS  PubMed  Google Scholar 

  15. Dvorak, C. C., Gracia, C. R., Sanders, J. E., Cheng, E. Y., Baker, K. S., Pulsipher, M. A., et al. (2011). NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: Endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks. Biol.Blood Marrow Transplant., 17(12), 1725–1738. https://doi.org/10.1016/j.bbmt.2011.10.006.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Cohen, A., Bekassy, A. N., Gaiero, A., Faraci, M., Zecca, S., Tichelli, A., et al. (2008). Endocrinological late complications after hematopoietic SCT in children. Bone Marrow Transplant, 41(Suppl 2), S43–S48. https://doi.org/10.1038/bmt.2008.54.

    Article  CAS  PubMed  Google Scholar 

  17. Clement-de, B. A., Oostdijk, W., Van Weel-Sipman, M. H., Van den Broeck, J., Wit, J. M., & Vossen, J. M. (1996). Final height and hormonal function after bone marrow transplantation in children. J.Pediatr., 129(4), 544–550.

    Article  Google Scholar 

  18. Sanders, J. E., Guthrie, K. A., Hoffmeister, P. A., Woolfrey, A. E., Carpenter, P. A., & Appelbaum, F. R. (2005). Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood, 105(3), 1348–1354. https://doi.org/10.1182/blood-2004-07-2528.

    Article  CAS  PubMed  Google Scholar 

  19. Brauner, R., Fontoura, M., Zucker, J. M., Devergie, A., Souberbielle, J. C., Prevot-Saucet, C., Michon, J., Gluckman, E., Griscelli, C., & Fischer, A. (1993). Growth and growth hormone secretion after bone marrow transplantation. Arch.Dis.Child, 68(4), 458–463.

    Article  CAS  Google Scholar 

  20. Rose, S. R., Lustig, R. H., Pitukcheewanont, P., Broome, D. C., Burghen, G. A., Li, H., et al. (1999). Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J.Clin.Endocrinol.Metab, 84(12), 4472–4479. https://doi.org/10.1210/jcem.84.12.6097.

    Article  CAS  PubMed  Google Scholar 

  21. Sanders, J. E., Pritchard, S., Mahoney, P., Amos, D., Buckner, C. D., Witherspoon, R. P., Deeg, H. J., Doney, K. C., Sullivan, K. M., & Appelbaum, F. R. (1986). Growth and development following marrow transplantation for leukemia. Blood, 68(5), 1129–1135.

    Article  CAS  Google Scholar 

  22. Ogilvy-Stuart, A. L., Clark, D. J., Wallace, W. H., Gibson, B. E., Stevens, R. F., Shalet, S. M., & Donaldson, M. D. (1992). Endocrine deficit after fractionated total body irradiation. Arch.Dis.Child, 67(9), 1107–1110.

    Article  CAS  Google Scholar 

  23. Michel, G., Socie, G., Gebhard, F., Bernaudin, F., Thuret, I., Vannier, J. P., et al. (1997). Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: The impact of conditioning regimen without total-body irradiation--a report from the Societe Francaise de Greffe de Moelle. J.Clin.Oncol., 15(6), 2238–2246.

    Article  CAS  Google Scholar 

  24. Berger, C., Le-Gallo, B., Donadieu, J., Richard, O., Devergie, A., Galambrun, C., et al. (2005). Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant, 35(10), 991–995. https://doi.org/10.1038/sj.bmt.1704945.

    Article  CAS  PubMed  Google Scholar 

  25. Sklar, C. A., Kim, T. H., & Ramsay, N. K. (1982). Thyroid dysfunction among long-term survivors of bone marrow transplantation. Am.J.Med., 73(5), 688–694. https://doi.org/10.1016/0002-9343(82)90411-9.

    Article  CAS  PubMed  Google Scholar 

  26. Boulad, F., Bromley, M., Black, P., Heller, G., Sarafoglou, K., Gillio, A., et al. (1995). Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplantation, 15(1), 71–76.

    CAS  PubMed  Google Scholar 

  27. Sklar, C., Boulad, F., Small, T., & Kernan, N. (2001). Endocrine complications of pediatric stem cell transplantation. Frontiers in Bioscience, 6, G17–G22.

    Article  CAS  Google Scholar 

  28. Cohen, A., Rovelli, A., Merlo, D. F., van Lint, M. T., Lanino, E., Bresters, D., et al. (2007). Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: An EBMT late effects working party study. J.Clin.Oncol., 25(17), 2449–2454. https://doi.org/10.1200/JCO.2006.08.9276.

    Article  PubMed  Google Scholar 

  29. Afify, Z., Shaw, P. J., Clavano-Harding, A., & Cowell, C. T. (2000). Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant., 25(10), 1087–1092. https://doi.org/10.1038/sj.bmt.1702384.

    Article  CAS  PubMed  Google Scholar 

  30. Sarafoglou, K., Boulad, F., Gillio, A., & Sklar, C. (1997). Gonadal function after bone marrow transplantation for acute leukemia during childhood. J. Pediatr., 130(2), 210–216. https://doi.org/10.1016/s0022-3476(97)70345-7.

    Article  CAS  PubMed  Google Scholar 

  31. Matsumoto, M., Shinohara, O., Ishiguro, H., Shimizu, T., Hattori, K., Ichikawa, M., et al. (1999). Ovarian function after bone marrow transplantation performed before menarche. Arch. Dis. Child, 80(5), 452–454.

    Article  CAS  Google Scholar 

  32. Sanders, J. E., Buckner, C. D., Amos, D., Levy, W., Appelbaum, F. R., Doney, K., Storb, R., Sullivan, K. M., Witherspoon, R. P., & Thomas, E. D. (1988). Ovarian function following marrow transplantation for aplastic anemia or leukemia. J.Clin.Oncol., 6(5), 813–818.

    Article  CAS  Google Scholar 

  33. Anderson, R. A., Mitchell, R. T., Kelsey, T. W., Spears, N., Telfer, E. E., & Wallace, W. H. (2015). Cancer treatment and gonadal function: Experimental and established strategies for fertility preservation in children and young adults. Lancet Diabetes Endocrinol, 3(7), 556–567. https://doi.org/10.1016/S2213-8587(15)00039-X.

    Article  CAS  PubMed  Google Scholar 

  34. Nakagawa, K., Kanda, Y., Yamashita, H., Nakagawa, S., Sasano, N., Ohtomo, K., et al. (2008). Ovarian shielding allows ovarian recovery and normal birth in female hematopoietic SCT recipients undergoing TBI. Bone Marrow Transplant, 42(10), 697–699. https://doi.org/10.1038/bmt.2008.234.

    Article  CAS  PubMed  Google Scholar 

  35. Assouline, E., Crocchiolo, R., Prebet, T., Broussais, F., Coso, D., Gamerre, M., et al. (2013). Impact of reduced-intensity conditioning allogeneic stem cell transplantation on women's fertility. Clinical Lymphoma, Myeloma & Leukemia, 13(6), 704–710. https://doi.org/10.1016/j.clml.2013.05.014.

    Article  Google Scholar 

  36. Sanders, J. E., Hawley, J., Levy, W., Gooley, T., Buckner, C. D., Deeg, H. J., Doney, K., Storb, R., Sullivan, K., Witherspoon, R., & Appelbaum, F. R. (1996). Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood, 87(7), 3045–3052.

    Article  CAS  Google Scholar 

  37. Bath, L. E., Critchley, H. O., Chambers, S. E., Anderson, R. A., Kelnar, C. J., & Wallace, W. H. (1999). Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: Response to sex steroid replacement. Br.J.Obstet.Gynaecol., 106(12), 1265–1272.

    Article  CAS  Google Scholar 

  38. Anserini, P., Chiodi, S., Spinelli, S., Costa, M., Conte, N., Copello, F., et al. (2002). Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplant, 30(7), 447–451. https://doi.org/10.1038/sj.bmt.1703651.

    Article  CAS  PubMed  Google Scholar 

  39. Rovo, A., Tichelli, A., Passweg, J. R., Heim, D., Meyer-Monard, S., Holzgreve, W., et al. (2006). Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD. Blood, 108(3), 1100–1105. https://doi.org/10.1182/blood-2006-01-0176.

    Article  CAS  PubMed  Google Scholar 

  40. Ishiguro, H., Yasuda, Y., Tomita, Y., Shinagawa, T., Shimizu, T., Morimoto, T., et al. (2007). Gonadal shielding to irradiation is effective in protecting testicular growth and function in long-term survivors of bone marrow transplantation during childhood or adolescence. Bone Marrow Transplant, 39(8), 483–490. https://doi.org/10.1038/sj.bmt.1705612.

    Article  CAS  PubMed  Google Scholar 

  41. Sklar, C. A., Robison, L. L., Nesbit, M. E., Sather, H. N., Meadows, A. T., Ortega, J. A., et al. (1990). Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: A report from the children Cancer study group. J.Clin.Oncol., 8(12), 1981–1987.

    Article  CAS  Google Scholar 

  42. Kaste, S. C., Shidler, T. J., Tong, X., Srivastava, D. K., Rochester, R., Hudson, M. M., et al. (2004). Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant, 10.1038/sj.bmt.1704360, 33(4), 435–441.

  43. Mostoufi-Moab, S., & Ward, L. M. (2018). Skeletal morbidity in children and adolescents during and following Cancer therapy. Hormone Research in Pædiatrics, 1–15. https://doi.org/10.1159/000494809.

  44. Mostoufi-Moab, S., Magland, J., Isaacoff, E. J., Sun, W., Rajapakse, C. S., Zemel, B., et al. (2015). Adverse fat depots and marrow adiposity are associated with skeletal deficits and insulin resistance in long-term survivors of pediatric hematopoietic stem cell transplantation. J.Bone Miner.Res., 30(9), 1657–1666. https://doi.org/10.1002/jbmr.2512.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Taskinen, M., Saarinen-Pihkala, U. M., Hovi, L., & Lipsanen-Nyman, M. (2000). Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet, 356(9234), 993–997. https://doi.org/10.1016/S0140-6736(00)02717-3.

    Article  CAS  PubMed  Google Scholar 

  46. Hoffmeister, P. A., Storer, B. E., & Sanders, J. E. (2004). Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation. J.Pediatr.Hematol.Oncol., 26(2), 81–90. https://doi.org/10.1097/00043426-200402000-00003.

    Article  PubMed  Google Scholar 

  47. Traggiai, C., Stanhope, R., Nussey, S., & Leiper, A. D. (2003). Diabetes mellitus after bone marrow transplantation during childhood. Med.Pediatr.Oncol., 40(2), 128–129. https://doi.org/10.1002/mpo.10098.

    Article  CAS  PubMed  Google Scholar 

  48. Chemaitilly, W., Boulad, F., Oeffinger, K. C., & Sklar, C. A. (2009). Disorders of glucose homeostasis in young adults treated with total body irradiation during childhood: A pilot study. Bone Marrow Transplant, 44(6), 339–343. https://doi.org/10.1038/bmt.2009.40.

    Article  CAS  PubMed  Google Scholar 

  49. Montero, N., & Pascual, J. (2015). Immunosuppression and post-transplant hyperglycemia. Current Diabetes Reviews, 11(3), 144–154.

    Article  CAS  Google Scholar 

  50. Chow, E. J., Liu, W., Srivastava, K., Leisenring, W. M., Hayashi, R. J., Sklar, C. A., et al. (2013). Differential effects of radiotherapy on growth and endocrine function among acute leukemia survivors: A childhood cancer survivor study report. Pediatr.Blood Cancer, 60(1), 110–115. https://doi.org/10.1002/pbc.24198.

    Article  PubMed  Google Scholar 

  51. Neville, K. A., Cohn, R. J., Steinbeck, K. S., Johnston, K., & Walker, J. L. (2006). Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: Prevalence and risk factors. J.Clin.Endocrinol.Metab, 91(11), 4401–4407. https://doi.org/10.1210/jc.2006-0128.

    Article  CAS  PubMed  Google Scholar 

  52. Meacham, L. R., Sklar, C. A., Li, S., Liu, Q., Gimpel, N., Yasui, Y., et al. (2009). Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: A report for the childhood cancer survivor study. Arch.Intern.Med., 169(15), 1381–1388. https://doi.org/10.1001/archinternmed.2009.209.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Wei, C., Thyagiarajan, M. S., Hunt, L. P., Shield, J. P., Stevens, M. C., & Crowne, E. C. (2015). Reduced insulin sensitivity in childhood survivors of haematopoietic stem cell transplantation is associated with lipodystropic and sarcopenic phenotypes. Pediatr.Blood Cancer, 62(11), 1992–1999. https://doi.org/10.1002/pbc.25601.

    Article  CAS  PubMed  Google Scholar 

  54. Wei, C., Thyagiarajan, M., Hunt, L., Cox, R., Bradley, K., Elson, R., et al. (2015). Reduced beta-cell reserve and pancreatic volume in survivors of childhood acute lymphoblastic leukaemia treated with bone marrow transplantation and total body irradiation. Clin.Endocrinol.(Oxf), 82(1), 59–67. https://doi.org/10.1111/cen.12575.

    Article  CAS  Google Scholar 

  55. de Vathaire, F., El-Fayech, C., Ben Ayed, F. F., Haddy, N., Guibout, C., Winter, D., et al. (2012). Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: A retrospective cohort study. The Lancet Oncology, 13(10), 1002–1010. https://doi.org/10.1016/S1470-2045(12)70323-6.

    Article  PubMed  Google Scholar 

  56. Oudin, C., Simeoni, M. C., Sirvent, N., Contet, A., Begu-Le, C. A., Bordigoni, P., et al. (2011). Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood, 117(17), 4442–4448. https://doi.org/10.1182/blood-2010-09-304899.

    Article  CAS  PubMed  Google Scholar 

  57. Paris, C., Yates, L., Lama, P., Zepeda, A. J., Gutierrez, D., & Palma, J. (2012). Evaluation of metabolic syndrome after hematopoietic stem cell transplantation in children and adolescents. Pediatric Blood & Cancer, 59(2), 306–310. https://doi.org/10.1002/pbc.24104.

    Article  Google Scholar 

  58. Armenian, S. H., Chemaitilly, W., Chen, M., Chow, E. J., Duncan, C. N., Jones, L. W., et al. (2016). National Institutes of Health hematopoietic cell transplantation late effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report. Biol Blood Marrow Transplant, 23, 201. https://doi.org/10.1016/j.bbmt.2016.08.019.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Turcotte, L. M., Yingst, A., & Verneris, M. R. (2016). Metabolic syndrome after hematopoietic cell transplantation: At the intersection of treatment toxicity and immune dysfunction. Biology of Blood and Marrow Transplantation, 22(7), 1159–1166. https://doi.org/10.1016/j.bbmt.2016.03.016.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Ness, K. K., Krull, K. R., Jones, K. E., Mulrooney, D. A., Armstrong, G. T., Green, D. M., et al. (2013). Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: A report from the St Jude lifetime cohort study. J.Clin.Oncol., 31(36), 4496–4503. https://doi.org/10.1200/JCO.2013.52.2268.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Chow, E. J., Anderson, L., Baker, K. S., Bhatia, S., Guilcher, G. M., Huang, J. T., Pelletier, W., Perkins, J. L., Rivard, L. S., Schechter, T., Shah, A. J., Wilson, K. D., Wong, K., Grewal, S. S., Armenian, S. H., Meacham, L. R., Mulrooney, D. A., & Castellino, S. M. (2016). Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: A Children's oncology group report. Biology of Blood and Marrow Transplantation, 22(5), 782–795. https://doi.org/10.1016/j.bbmt.2016.01.023.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Kremer, L. C., Mulder, R. L., Oeffinger, K. C., Bhatia, S., Landier, W., Levitt, G., et al. (2013). A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: A report from the international late effects of childhood Cancer guideline harmonization group. Pediatr.Blood Cancer, 60(4), 543–549. https://doi.org/10.1002/pbc.24445.

    Article  PubMed  Google Scholar 

  63. Sklar, C. A., Antal, Z., Chemaitilly, W., Cohen, L. E., Follin, C., Meacham, L. R., et al. (2018). Hypothalamic-pituitary and growth disorders in survivors of childhood Cancer: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 103, 2761. https://doi.org/10.1210/jc.2018-01175.

    Article  PubMed  Google Scholar 

  64. Sfeir, J. G., Kittah, N. E., Tamhane, S. U., Jasim, S., Chemaitilly, W., Cohen, L., et al. (2018). Diagnosis of growth hormone deficiency as a late effect of radiotherapy in survivors of childhood cancers. The Journal of Clinical Endocrinology and Metabolism. https://doi.org/10.1210/jc.2018-01204.

  65. Tamhane, S., Sfeir, J. G., Kittah, N. E. N., Jasim, S., Chemaitilly, W., Cohen, L. E., et al. (2018). Growth hormone therapy in childhood Cancer Survivors: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2018-01205.

  66. Raman, S., Grimberg, A., Waguespack, S. G., Miller, B. S., Sklar, C. A., Meacham, L. R., et al. (2015). Risk of Neoplasia in pediatric patients receiving growth hormone therapy - a report from the pediatric Endocrine Society drug and therapeutics committee. J.Clin.Endocrinol.Metab. https://doi.org/10.1210/jc.2015-1002.

  67. Leschek, E. W., Rose, S. R., Yanovski, J. A., Troendle, J. F., Quigley, C. A., Chipman, J. J., et al. (2004). Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: A randomized, double-blind, placebo-controlled trial. The Journal of Clinical Endocrinology and Metabolism, 89(7), 3140–3148. https://doi.org/10.1210/jc.2003-031457.

    Article  CAS  PubMed  Google Scholar 

  68. Mauras, N., Ross, J. L., Gagliardi, P., Yu, Y. M., Hossain, J., Permuy, J., Damaso, L., Merinbaum, D., Singh, R. J., Gaete, X., & Mericq, V. (2016). Randomized trial of aromatase inhibitors, growth hormone, or combination in pubertal boys with idiopathic, short stature. The Journal of Clinical Endocrinology and Metabolism, 101(12), 4984–4993. https://doi.org/10.1210/jc.2016-2891.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Chemaitilly, W., Cohen, L. E., Mostoufi-Moab, S., Patterson, B. C., Simmons, J. H., Meacham, L. R., van Santen, H., & Sklar, C. A. (2018). Endocrine late effects in childhood Cancer survivors. Journal of Clinical Oncology, 36(21), 2153–2159. https://doi.org/10.1200/JCO.2017.76.3268.

    Article  CAS  PubMed  Google Scholar 

  70. Clement, S. C., Kremer, L. C. M., Verburg, F. A., Simmons, J. H., Goldfarb, M., Peeters, R. P., Alexander, E. K., Bardi, E., Brignardello, E., Constine, L. S., Dinauer, C. A., Drozd, V. M., Felicetti, F., Frey, E., Heinzel, A., van den Heuvel-Eibrink, M., Huang, S. A., Links, T. P., Lorenz, K., Mulder, R. L., Neggers, S. J., Nieveen van Dijkum, E., Oeffinger, K. C., van Rijn, R., Rivkees, S. A., Ronckers, C. M., Schneider, A. B., Skinner, R., Wasserman, J. D., Wynn, T., Hudson, M. M., Nathan, P. C., & van Santen, H. (2018). Balancing the benefits and harms of thyroid cancer surveillance in survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood Cancer guideline harmonization group in collaboration with the PanCareSurFup consortium. Cancer Treatment Reviews, 63, 28–39. https://doi.org/10.1016/j.ctrv.2017.11.005.

    Article  CAS  PubMed  Google Scholar 

  71. Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., et al. (2015). Management guidelines for children with thyroid nodules and differentiated thyroid Cancer. Thyroid, 25(7), 716–759. https://doi.org/10.1089/thy.2014.0460.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., et al. (2009). Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19(11), 1167–1214. https://doi.org/10.1089/thy.2009.0110.

    Article  PubMed  Google Scholar 

  73. Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018). Testosterone therapy in men with Hypogonadism: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 103(5), 1715–1744. https://doi.org/10.1210/jc.2018-00229.

    Article  PubMed  Google Scholar 

  74. Palmert, M. R., & Dunkel, L. (2012). Clinical practice. Delayed puberty. The New England Journal of Medicine, 366(5), 443–453. https://doi.org/10.1056/NEJMcp1109290.

    Article  CAS  PubMed  Google Scholar 

  75. Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., et al. (2016). Hormonal replacement in hypopituitarism in adults: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 101(11), 3888–3921. https://doi.org/10.1210/jc.2016-2118.

    Article  CAS  PubMed  Google Scholar 

  76. Moskowitz, C. S., Chou, J. F., Sklar, C. A., Barnea, D., Ronckers, C. M., Friedman, D. N., Neglia, J. P., Turcotte, L., Howell, R. M., Henderson, T. O., Armstrong, G. T., Leisenring, W. M., Robison, L. L., van Leeuwen, F. E., Pike, M. C., & Oeffinger, K. C. (2017). Radiation-associated breast cancer and gonadal hormone exposure: A report from the childhood Cancer survivor study. British Journal of Cancer, 117, 290–299. https://doi.org/10.1038/bjc.2017.169.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Kenney, L. B., Cohen, L. E., Shnorhavorian, M., Metzger, M. L., Lockart, B., Hijiya, N., et al. (2012). Male reproductive health after childhood, adolescent, and young adult cancers: A report from the Children's oncology group. J.Clin.Oncol, 30(27), 3408–3416. https://doi.org/10.1200/JCO.2011.38.6938.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Metzger, M. L., Meacham, L. R., Patterson, B., Casillas, J. S., Constine, L. S., Hijiya, N., et al. (2013). Female reproductive health after childhood, adolescent, and young adult cancers: Guidelines for the assessment and management of female reproductive complications. J.Clin.Oncol, 31(9), 1239–1247. https://doi.org/10.1200/JCO.2012.43.5511.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Alexandroni, H., Shoham, G., Levy-Toledano, R., Nagler, A., Mohty, M., Duarte, R., Leong, M., & Shoham, Z. (2019). Fertility preservation from the point of view of hematopoietic cell transplant specialists-a worldwide-web-based survey analysis. Bone Marrow Transplantation, 54, 1747–1755. https://doi.org/10.1038/s41409-019-0519-z.

    Article  PubMed  Google Scholar 

  80. Wasilewski-Masker, K., Kaste, S. C., Hudson, M. M., Esiashvili, N., Mattano, L. A., & Meacham, L. R. (2008). Bone mineral density deficits in survivors of childhood cancer: Long-term follow-up guidelines and review of the literature. Pediatrics, 121(3), e705–e713. https://doi.org/10.1542/peds.2007-1396.

    Article  PubMed  Google Scholar 

  81. Carpenter, P. A., Hoffmeister, P., Chesnut 3rd, C. H., Storer, B., Charuhas, P. M., Woolfrey, A. E., et al. (2007). Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 13(6), 683–690. https://doi.org/10.1016/j.bbmt.2007.02.001.

    Article  CAS  PubMed  Google Scholar 

  82. Marini, J. C. (2003). Do bisphosphonates make children's bones better or brittle? The New England Journal of Medicine, 349(5), 423–426. https://doi.org/10.1056/NEJMp038103.

    Article  PubMed  Google Scholar 

  83. Blaser, B. W., Kim, H. T., Alyea 3rd, E. P., Ho, V. T., Cutler, C., Armand, P., et al. (2012). Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 18(4), 575–583. https://doi.org/10.1016/j.bbmt.2011.08.003.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge Nisha Badders, PhD, ELS, for her assistance with editing the manuscript.

Author information

Authors and Affiliations

  1. Pediatric Endocrinology-Diabetology, Klinik für Kinder- und Jugendmedizin, University Clinic of Frankfurt, Frankfurt am Main, Germany

    Ulrich Paetow

  2. Division of Stem Cell Transplantation and Immunology, Klinik für Kinder- und Jugendmedizin, University Clinic of Frankfurt, Frankfurt am Main, Germany

    Peter Bader

  3. Department of Pediatric Medicine, Division of Endocrinology, St. Jude Children’s Research Hospital, Memphis, TN, USA

    Wassim Chemaitilly

Authors
  1. Ulrich Paetow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Bader
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wassim Chemaitilly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wassim Chemaitilly.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Paetow, U., Bader, P. & Chemaitilly, W. A systematic approach to the endocrine care of survivors of pediatric hematopoietic stem cell transplantation. Cancer Metastasis Rev 39, 69–78 (2020). https://doi.org/10.1007/s10555-020-09864-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10555-020-09864-z

Keywords

Search

Navigation